13F-HR filed by ADAR1 Capital Management, LLC
ADAR1 Capital Management, LLC filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-18, with 310 holding rows worth $1,698,675,488.
- Accession
- 0001940272-26-000005
- Filer
- CIK 1940272
- Filed
- 2026-05-18
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2026
A holdings report, 311 entries on the cover page, a total value of $1,698,675,488 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,698,675,488 with VALUE read as dollars as filed, 13F file number 028-23931. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 1,394,019 | $155,224,016 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 994,119 | $104,780,143 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 3,285,906 | $91,019,596 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 2,679,010 | $66,546,608 | dollars as filed | |
| SPY | 78462F103 | SHS | 75,940 | $49,386,820 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 914,699 | $48,222,931 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 632,556 | $41,691,766 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 1,139,331 | $41,380,502 | dollars as filed | |
| EA SERIES TRUST | 02072L565 | ALPHA ARCH 1-3 | 337,125 | $39,204,266 | dollars as filed | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 1,871,455 | $35,931,936 | dollars as filed | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 1,446,375 | $34,467,116 | dollars as filed | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 1,425,367 | $26,811,153 | dollars as filed | |
| SEPTERNA INC COM | 81734D104 | Stock | 1,089,818 | $26,188,327 | dollars as filed | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 2,744,714 | $24,592,637 | dollars as filed | |
| DBV TECHNOLOGIES S A | 23306J309 | SPONSORED ADS | 1,012,866 | $21,158,771 | dollars as filed | |
| ANTERIS TECHNOLOGIES GLOBAL | 03675P102 | COMMON STOCK | 3,789,132 | $21,029,683 | dollars as filed | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 405,197 | $20,900,061 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 407,273 | $20,021,541 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 211,450 | $18,389,807 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 338,323 | $17,065,012 | dollars as filed | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 3,410,190 | $16,027,893 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 1,581,443 | $15,371,626 | dollars as filed | |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 316,939 | $15,270,121 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 259,137 | $15,058,451 | dollars as filed | |
| MONOPAR THERAPEUTICS INC | 61023L207 | COMMON STOCK | 264,278 | $14,479,792 | dollars as filed | |
| Arbutus Biopharma Corp | 03879J100 | Common Shares, without par value | 3,133,175 | $14,099,288 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 1,000,604 | $13,908,396 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 427,816 | $13,570,324 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 2,979,429 | $13,318,048 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 228,899 | $13,310,477 | dollars as filed | |
| SUTRO BIOPHARMA INC | 869367201 | COMMON STOCK | 524,441 | $13,063,825 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 133,893 | $13,021,094 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 329,540 | $12,917,968 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 185,699 | $12,568,108 | dollars as filed | |
| SPDR Bloomberg 1-3 Month T-Bill ETF | 78468R663 | SHS | 135,585 | $12,425,009 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 213,473 | $12,120,997 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 1,582,987 | $12,109,851 | dollars as filed | |
| INVENTIVA SA | 46124U107 | ADS | 2,174,398 | $12,067,909 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 160,338 | $12,039,780 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 161,252 | $11,602,081 | dollars as filed | |
| INHIBIKASE THERAPEUTICS INC | 45719W205 | COMMON STOCK | 6,606,572 | $11,099,041 | dollars as filed | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 1,361,536 | $10,933,134 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 200,000 | $10,544,000 | dollars as filed | call |
| HELIX ACQUISITION CORP III | G4444S107 | USD CL A ORD SHS | 1,000,000 | $10,300,000 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 4,544,113 | $10,087,931 | dollars as filed | |
| ONKURE THERAPEUTICS INC | 68277Q105 | COM CL A | 2,434,941 | $10,080,656 | dollars as filed | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 12,154 | $9,390,667 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 457,137 | $8,521,034 | dollars as filed | |
| LEXEO THERAPEUTICS INC | 52886X107 | COMMON STOCK | 1,467,350 | $8,422,589 | dollars as filed | |
| OPUS GENETICS INC | 67577R102 | COMMON STOCK | 1,849,004 | $8,412,968 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 268,391 | $8,083,937 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 1,464,535 | $7,996,361 | dollars as filed | |
| MAPLIGHT THERAPEUTICS INC | 56565P103 | COMMON STOCK | 374,909 | $7,621,900 | dollars as filed | |
| LeonaBio Inc | 04746L203 | COM | 727,481 | $7,478,505 | dollars as filed | |
| EQUILLIUM INC | 29446K106 | COM | 3,726,659 | $7,453,318 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 227,717 | $7,409,911 | dollars as filed | |
| DAMORA THERAPEUTICS INC | 36322Q206 | COMMON STOCK | 279,000 | $7,226,100 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 395,459 | $7,110,353 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 94,292 | $7,002,124 | dollars as filed | |
| PRIME MEDICINE INC | 74168J101 | COM | 1,973,282 | $6,867,021 | dollars as filed | |
| iShares Russell 2000 ETF | 464287655 | SHS | 27,500 | $6,820,000 | dollars as filed | put |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 15,075 | $6,731,591 | dollars as filed | |
| KORRO BIO INC | 500946108 | COMMON STOCK | 540,054 | $6,113,411 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 304,422 | $5,954,494 | dollars as filed | |
| Danaher Corporation | 235851102 | COM | 30,932 | $5,864,707 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 35,392 | $5,787,300 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 25,014 | $5,721,452 | dollars as filed | |
| BRIGHTHOUSE FINL INC | 10922N103 | COM | 95,523 | $5,719,917 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 262,058 | $5,702,382 | dollars as filed | |
| OAKTREE ACQUISITION CORP III | G6717R120 | UNIT 10/04/2029 | 516,482 | $5,500,533 | dollars as filed | |
| PERCEPTIVE CAPITAL SOLUTIONS | G70077105 | CL A ORD SHS | 499,581 | $5,480,404 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 20,014 | $5,170,016 | dollars as filed | |
| ACUMEN PHARMACEUTICALS INC | 00509G209 | CMN | 2,156,334 | $5,088,948 | dollars as filed | |
| INVIVYD INC | 00534A102 | COMMON STOCK | 3,822,427 | $4,969,155 | dollars as filed | |
| Bridgebio Pharma Inc Note 2.250 percent 2/0 | 10806XAD4 | Convertible | 45,000 | $4,943,000 | dollars as filed | principal |
| Bhav Acquisition Corp Unit 03/18/2031 | G1R59W127 | Unit | 495,000 | $4,935,000 | dollars as filed | |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 940,512 | $4,900,068 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 44,000 | $4,899,400 | dollars as filed | call |
| BRIDGEBIO PHARMA INC | 10806XAJ1 | NOTE 1.750% 3/0 | 30,000 | $4,852,000 | dollars as filed | principal |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 140,672 | $4,758,934 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 5,060 | $4,654,036 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 55,000 | $4,615,600 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 70,300 | $4,407,810 | dollars as filed | |
| BELITE BIO INC | 07782B104 | CMN | 26,880 | $4,285,747 | dollars as filed | |
| EVOMMUNE INC | 30054Y107 | COMMON STOCK | 184,062 | $4,231,585 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 154,686 | $4,190,444 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 298,546 | $4,149,789 | dollars as filed | |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 597,662 | $4,093,985 | dollars as filed | |
| PALISADE BIO INC | 696389402 | COMMON STOCK | 2,264,845 | $3,963,479 | dollars as filed | |
| AMERICAN EXCEPTIONALISM ACQU | G0273J101 | ORD CL A | 357,539 | $3,872,147 | dollars as filed | |
| SPRUCE BIOSCIENCES INC | 85209E208 | COM NEW | 58,600 | $3,829,510 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 118,623 | $3,797,122 | dollars as filed | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 100,000 | $3,774,000 | dollars as filed | put |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 630,403 | $3,750,898 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 32,084 | $3,683,885 | dollars as filed | |
| CONTINEUM THERAPEUTICS INC CL A | 21217B100 | Stock | 276,661 | $3,613,193 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806XAB8 | NOTE 2.500% 3/1 | 20,000 | $3,564,000 | dollars as filed | principal |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 215,752 | $3,549,120 | dollars as filed | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 11,701 | $3,474,846 | dollars as filed | |
| TENAX THERAPEUTICS INC | 88032L605 | COM NEW | 213,462 | $3,413,257 | dollars as filed | |
| ARRIVENT BIOPHARMA INC | 04272N102 | COM | 141,814 | $3,271,649 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 2,585,126 | $3,257,259 | dollars as filed | |
| ATAIBECKLEY INC | 04650F101 | COM SHS | 913,242 | $3,232,877 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 451,918 | $3,145,349 | dollars as filed | |
| PERSPECTIVE THERAPEUTICS INC | 46489V302 | COMMON STOCK | 749,335 | $3,124,727 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 331,781 | $3,115,424 | dollars as filed | |
| ELEDON PHARMACEUTICALS INC | 28617k101 | COM | 974,421 | $3,001,217 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 105,528 | $2,981,166 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 72,500 | $2,916,675 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 90,599 | $2,853,869 | dollars as filed | |
| PEPGEN INC COM | 713317105 | Stock | 1,607,638 | $2,845,519 | dollars as filed | |
| CAPRICOR THERAPEUTICS INC | 14070B309 | COMMON STOCK | 90,593 | $2,754,027 | dollars as filed | |
| MASIMO CORP COM | 574795100 | Stock | 15,000 | $2,668,050 | dollars as filed | |
| INOVIO PHARMACEUTICALS I | 45773H409 | COMMON STOCK | 1,470,108 | $2,557,988 | dollars as filed | |
| TELEFLEX INCORPORATED | 879369106 | COM | 21,186 | $2,534,057 | dollars as filed | |
| BRIGHT MINDS BIOSCIENCES INC | 10919W405 | COMMON STOCK | 33,900 | $2,473,683 | dollars as filed | |
| BIOAGE LABS INC COM | 09077V100 | Stock | 135,560 | $2,370,944 | dollars as filed | |
| ALECTOR INC | 014442107 | COMMON STOCK | 1,050,000 | $2,257,500 | dollars as filed | |
| Pfizer Inc. | 717081103 | COM | 77,400 | $2,173,392 | dollars as filed | |
| DELCATH SYSTEMS INC | 24661P807 | COMMON STOCK | 224,385 | $2,082,293 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 11,000 | $2,016,630 | dollars as filed | |
| CONNECT BIOPHARMA HLDGS LTD | G23549101 | SHS | 742,400 | $1,945,088 | dollars as filed | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 15,000 | $1,915,950 | dollars as filed | put |
| SUMMIT THERAPEUTICS INC | 86627T108 | COM | 91,869 | $1,741,836 | dollars as filed | |
| GLOBUS MED INC CL A | 379577208 | Stock | 20,100 | $1,731,816 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 46,400 | $1,640,704 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 100,000 | $1,635,000 | dollars as filed | call |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 46,830 | $1,567,868 | dollars as filed | |
| Cohen Circle Acquisit Corp I Unit 07/01/2030 | G2254C105 | Unit | 150,000 | $1,551,000 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 432,500 | $1,548,350 | dollars as filed | |
| SUPERNUS PHARMACEUTICALS | 868459108 | COM | 29,642 | $1,532,195 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 38,566 | $1,531,842 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 105,000 | $1,518,300 | dollars as filed | |
| MAZE THERAPEUTICS INC COM | 578784100 | Stock | 50,095 | $1,495,336 | dollars as filed | |
| UnitedHealth Group Inc | 91324P102 | COM | 5,501 | $1,488,516 | dollars as filed | |
| Adagio Med Hldgs Inc Com | 00534B100 | Common Stock | 1,205,447 | $1,386,264 | dollars as filed | |
| FORWARD AIR CORP COM | 34986A104 | Stock | 78,241 | $1,307,407 | dollars as filed | |
| SENSIENT TECHNOLOGIES CORP | 81725T100 | COM | 15,000 | $1,296,600 | dollars as filed | |
| KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A | G52694109 | Stock | 26,913 | $1,295,861 | dollars as filed | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 87,901 | $1,285,992 | dollars as filed | |
| SATELLOS BIOSCIENCE INC | 80401L803 | COM | 222,555 | $1,253,000 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 76,206 | $1,245,968 | dollars as filed | |
| NOVO-NORDISK A S ADR | 670100205 | ADR | 33,000 | $1,212,750 | dollars as filed | |
| PROMIS NEUROSCIENCES INC | 74346M505 | COM SHS | 95,350 | $1,210,945 | dollars as filed | |
| LEXICON PHARMACEUTICALS INC | 528872302 | COMMON STOCK | 750,000 | $1,170,000 | dollars as filed | |
| SCHRODINGER INC COM | 80810D103 | Stock | 101,500 | $1,153,040 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U205 | COMMON STOCK | 205,200 | $1,142,964 | dollars as filed | call |
| XENCOR INC | 98401F105 | COMMON STOCK | 93,665 | $1,129,600 | dollars as filed | |
| OMNIAB INC | 68218J103 | COM | 705,190 | $1,107,148 | dollars as filed | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 116,712 | $1,086,589 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 97,318 | $1,074,391 | dollars as filed | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 49,923 | $1,070,349 | dollars as filed | |
| Bristol-Myers Squibb Company | 110122108 | COM | 17,500 | $1,061,375 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 50,000 | $1,046,000 | dollars as filed | |
| TENAYA THERAPEUTICS INC | 87990A106 | COM | 1,507,800 | $1,044,001 | dollars as filed | |
| BEST SPAC I ACQUISITION CORP | G1069P137 | UNIT 05/27/2030 | 100,000 | $1,040,000 | dollars as filed | |
| MCKESSON CORP COM | 58155Q103 | Stock | 1,200 | $1,038,432 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 18,200 | $1,028,118 | dollars as filed | |
| Arrowhead Pharmaceuticals In Note 1/1 | 04280AAC4 | Convertible | 10,000 | $1,024,000 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 20,840 | $1,022,202 | dollars as filed | |
| ELECTRONIC ARTS INC COM | 285512109 | Stock | 4,936 | $1,006,302 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 130,560 | $1,001,395 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 105,000 | $999,600 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 10,000 | $923,700 | dollars as filed | |
| CRESCENT BIOPHARMA INC | G2545C104 | COMMON STOCK | 50,273 | $923,515 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 351,094 | $919,866 | dollars as filed | |
| ENGENE HOLDINGS INC | 29286M105 | COM | 133,686 | $910,402 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 172,157 | $907,267 | dollars as filed | |
| ALEXANDRIA REAL ESTATE EQ INC COM | 015271109 | REIT | 19,500 | $905,190 | dollars as filed | |
| KEEN VISION ACQUISITION CORP | G52443119 | SHS | 75,000 | $900,000 | dollars as filed | call |
| IBIO INC | 451033708 | CMN | 469,878 | $892,768 | dollars as filed | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 10,000 | $888,800 | dollars as filed | |
| Gilead Sciences,Inc. | 375558103 | COM | 6,351 | $885,139 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 56,070 | $869,085 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 47,463 | $860,504 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 1,830 | $843,612 | dollars as filed | |
| Adlai Nortye | 00704R109 | SPONSORED ADS | 117,909 | $815,930 | dollars as filed | |
| WW INTL INC | 98262P200 | COM NEW | 57,700 | $792,798 | dollars as filed | |
| ATRIUM THERAPEUTICS INC COM | 04965N104 | Stock | 57,688 | $771,000 | dollars as filed | |
| INTEGER HLDGS CORP | 45826H109 | COM | 8,750 | $770,000 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 100,000 | $765,000 | dollars as filed | call |
| KARYOPHARM THERAPEUTICS INC | 48576U205 | COMMON STOCK | 136,736 | $761,620 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 139,000 | $735,310 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 6,942 | $711,208 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 50,000 | $710,500 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 20,000 | $666,400 | dollars as filed | |
| FRACTYL HEALTH INC | 35168W103 | COM | 1,428,571 | $654,000 | dollars as filed | call |
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 51,357 | $648,639 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 16,033 | $645,008 | dollars as filed | |
| VYNE THERAPEUTICS INC | 92941V308 | COM | 1,063,899 | $635,680 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 10,000 | $627,500 | dollars as filed | |
| AVANTOR INC COM | 05352A100 | Stock | 80,000 | $627,200 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 57,591 | $610,465 | dollars as filed | |
| KEZAR LIFE SCIENCES INC | 49372L209 | COM NEW | 81,933 | $607,943 | dollars as filed | |
| KALARIS THERAPEUTICS INC | 482929106 | COM | 100,000 | $577,000 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 6,200 | $572,756 | dollars as filed | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 3,000 | $567,150 | dollars as filed | |
| ASSEMBLY BIOSCIENCES INC | 045396207 | COMMON STOCK | 19,947 | $553,529 | dollars as filed | |
| PRELUDE THERAPEUTICS INC | 74065P101 | CMN | 152,825 | $522,662 | dollars as filed | |
| Globa Terra Acquisition Cor Unit 99/99/9999 | G3933N108 | Unit | 50,000 | $518,000 | dollars as filed | |
| WISDOMTREE TR | 97717Y527 | FLOATNG RAT TREA | 10,000 | $503,400 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 132,426 | $496,598 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 1,500 | $483,285 | dollars as filed | |
| PULMONX CORP | 745848101 | COM | 374,497 | $483,101 | dollars as filed | |
| ELANCO ANIMAL HEALTH INC COM | 28414H103 | Stock | 20,000 | $478,600 | dollars as filed | |
| NOVO-NORDISK A S ADR | 670100205 | ADR | 13,000 | $477,750 | dollars as filed | call |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 42,900 | $476,619 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 895 | $468,506 | dollars as filed | |
| POLYPID LTD | M8001Q126 | COM | 103,950 | $455,301 | dollars as filed | |
| ALIBABA GROUP HLDG LTD | 01609W102 | SPONSORED ADS | 3,578 | $448,896 | dollars as filed | |
| CORE SCIENTIFIC INC NEW | 21874A106 | COM | 30,000 | $448,800 | dollars as filed | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 128,503 | $443,335 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 2,147 | $429,379 | dollars as filed | |
| VISTAGEN THERAPEUTICS INC | 92840H400 | COM | 751,141 | $429,277 | dollars as filed | |
| THERAPEUTICSMD INC | 88338N206 | COM NEW | 209,210 | $422,604 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 20,000 | $419,000 | dollars as filed | call |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 17,500 | $408,800 | dollars as filed | |
| TECTONIC THERAPEUTIC INC | 878972108 | COMMON STOCK | 13,001 | $401,861 | dollars as filed | |
| ENTRADA THERAPEUTICS INC COM | 29384C108 | Stock | 30,500 | $384,910 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 44,777 | $378,813 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 3,140 | $377,711 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 71,100 | $376,830 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 20,000 | $372,800 | dollars as filed | call |
| REGENXBIO INC | 75901B107 | COM | 44,416 | $372,206 | dollars as filed | |
| ADICET BIO INC | 007002207 | COM NEW | 53,827 | $366,562 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 20,000 | $361,800 | dollars as filed | |
| SURROZEN INC | 86889P208 | COMMON STOCK | 12,000 | $349,560 | dollars as filed | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 144,636 | $338,448 | dollars as filed | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 71,298 | $330,823 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 2,500 | $329,350 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 35,000 | $328,650 | dollars as filed | call |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 44,900 | $325,525 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 40,000 | $325,200 | dollars as filed | |
| KIORA PHARMACEUTICALS INC | 49721T507 | COM | 167,941 | $324,126 | dollars as filed | |
| CORCEPT THERAPEUTICS INC | 218352102 | COM | 8,000 | $322,480 | dollars as filed | |
| UPSTREAM BIO INC | 91678A107 | COMMON STOCK | 35,000 | $315,000 | dollars as filed | |
| ORTHOPEDIATRICS CORP | 68752L100 | COMMON STOCK | 19,845 | $314,940 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 55,000 | $304,700 | dollars as filed | |
| GERON CORP | 374163103 | COM | 200,000 | $298,000 | dollars as filed | |
| JD.COM INC SPON ADS CL A | 47215P106 | ADR | 10,000 | $295,700 | dollars as filed | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 231,008 | $286,450 | dollars as filed | |
| TRAWS PHARMA INC | 68232V884 | COM NEW | 154,098 | $281,999 | dollars as filed | |
| JADE BIOSCIENCES INC | 008064206 | COM NEW | 20,000 | $281,000 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 13,400 | $280,730 | dollars as filed | |
| PROCAP ACQUISITION CORP | G7257A113 | UNIT 05/16/2030 | 26,940 | $278,560 | dollars as filed | |
| BICARA THERAPEUTICS INC | 055477103 | COM | 13,705 | $272,592 | dollars as filed | |
| RXSIGHT INC | 78349D107 | COM | 43,250 | $266,420 | dollars as filed | |
| PALO ALTO NETWORKS INC | 697435105 | COM | 1,600 | $256,512 | dollars as filed | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 19,517 | $250,208 | dollars as filed | |
| CROWDSTRIKE HLDGS INC | 22788C105 | COM | 640 | $249,862 | dollars as filed | |
| RUBRIK INC. | 781154109 | CL A | 4,900 | $239,953 | dollars as filed | |
| ROYALTY PHARMA PLC | G7709Q104 | SHS CLASS A | 5,000 | $239,850 | dollars as filed | |
| SURGERY PARTNERS INC | 86881A100 | COM | 20,000 | $238,400 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 52,745 | $237,353 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 55,859 | $229,580 | dollars as filed | |
| Q32 BIO INC | 746964105 | Common Stock | 35,000 | $224,700 | dollars as filed | |
| LONGEVERON INC | 54303L203 | CL A NEW | 200,000 | $208,000 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 3,698 | $205,091 | dollars as filed | |
| CANTOR EQUITY PARTNERS VI IN | G1828R101 | CL A ORD SHS | 20,000 | $202,000 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 10,000 | $201,300 | dollars as filed | |
| KYVERNA THERAPEUTICS INC | 501976104 | COMMON STOCK | 22,428 | $193,554 | dollars as filed | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 43,500 | $186,615 | dollars as filed | |
| BENITEC BIOPHARMA INC | 08205P209 | COMMON STOCK | 17,500 | $186,375 | dollars as filed | |
| LIPOCINE INC NEW | 53630X203 | COM NEW | 23,180 | $185,208 | dollars as filed | |
| RALLYBIO CORP | 75120L209 | COM | 20,535 | $184,199 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 58,679 | $178,971 | dollars as filed | |
| Q C Technologies Inc | 62856X300 | COM | 50,000 | $172,500 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 10,000 | $161,800 | dollars as filed | |
| COYA THERAPEUTICS INC | 22407B108 | CMN | 40,900 | $161,146 | dollars as filed | |
| PERSONALIS INC | 71535D106 | COMMON STOCK | 25,000 | $159,250 | dollars as filed | |
| SI BONE INC | 825704109 | COM | 12,580 | $158,885 | dollars as filed | |
| STARLING ONCOLOGY INC | 68236X100 | COMMON STOCK | 50,000 | $153,500 | dollars as filed | |
| CYBIN INC | 23256X407 | COM NEW | 31,278 | $150,134 | dollars as filed | |
| NEURONETICS INC | 64131A105 | COM | 100,000 | $145,000 | dollars as filed | |
| ARDELYX INC | 039697107 | COM | 23,900 | $143,161 | dollars as filed | |
| Inflarx Nv | N44821101 | COM | 158,271 | $141,558 | dollars as filed | |
| ACHIEVE LIFE SCIENCES INC | 004468500 | COMMON STOCK | 47,800 | $140,532 | dollars as filed | |
| VOYAGER THERAPEUTICS INC | 92915B106 | COMMON STOCK | 35,000 | $135,100 | dollars as filed | |
| CHEMOMAB THERAPEUTICS LTD | 16385C203 | SPONSORED ADS | 80,000 | $125,600 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871202 | COM NEW | 140,000 | $122,668 | dollars as filed | |
| NEUPHORIA THERAPEUTICS INC | 64136E102 | COM | 30,000 | $122,100 | dollars as filed | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 100,000 | $119,000 | dollars as filed | |
| ARCTURUS THERAPEUTICS HLDGS | 03969T109 | COM | 15,000 | $115,800 | dollars as filed | |
| MACROGENICS INC | 556099109 | COM | 40,000 | $115,600 | dollars as filed | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 43,000 | $113,090 | dollars as filed | |
| RECURSION PHARMACEUTICALS IN | 75629V104 | CL A | 35,000 | $107,450 | dollars as filed | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 10,000 | $106,400 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 287,531 | $94,454 | dollars as filed | |
| IMMIX BIOPHARMA INC | 45258H106 | COMMON STOCK | 10,000 | $91,100 | dollars as filed | |
| SOLIDION TECHNOLOGY INC | 834212201 | COM NEW | 13,500 | $85,185 | dollars as filed | call |
| LITE STRATEGY INC | 55279B301 | COM | 67,292 | $78,059 | dollars as filed | |
| VERU INC | 92536C202 | COM NEW | 35,000 | $77,350 | dollars as filed | |
| KYNTRA BIO INC | 31572Q881 | COM NEW | 10,469 | $70,980 | dollars as filed | |
| CLOVER HEALTH INVESTMENTS CO | 18914F103 | COMMON STOCK | 40,000 | $70,400 | dollars as filed | |
| BIOMEA FUSION INC | 09077A106 | CMN | 43,420 | $66,433 | dollars as filed | |
| NEUMORA THERAPEUTICS INC. | 640979100 | COM | 33,100 | $64,545 | dollars as filed | |
| ORGANON & CO COMMON STOCK | 68622V106 | Stock | 10,000 | $59,900 | dollars as filed | |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 21,400 | $58,636 | dollars as filed | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 150,000 | $49,500 | dollars as filed | |
| AN2 THERAPEUTICS INC | 037326105 | COM | 13,861 | $47,405 | dollars as filed | |
| A SPAC III ACQUISITION CORP | G0544A145 | RIGHT 01/02/2026 | 215,000 | $42,441 | dollars as filed | |
| AQUESTIVE THERAPEUTICS INC COM | 03843E104 | Stock | 10,000 | $41,500 | dollars as filed | |
| ATYR PHARMA INC | 002120202 | COM NEW | 50,685 | $39,534 | dollars as filed | |
| BIOATLA INC | 09077B104 | COM | 228,107 | $36,725 | dollars as filed | |
| KALA BIO INC | 483119202 | COM NEW | 141,480 | $24,490 | dollars as filed | |
| COHERUS ONCOLOGY INC | 19249H103 | COM | 10,366 | $17,519 | dollars as filed | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 10,000 | $16,200 | dollars as filed | |
| CORTEXYME INC | 22053A107 | COM | 50,100 | $5,080 | dollars as filed | |
| CORTEXYME INC | 22053A107 | COM | 50,000 | $5,070 | dollars as filed | put |
| IMMUNIC INC | 4525EP101 | COM | 30,000 | $0 | dollars as filed | Value filed as zero, left out of ratios. |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001940272-26-000005 | this filing | 2026-05-18 | acceptance time not in the bulk data set |